Makkah, a city that sees millions of visitors every year, quietly holds a piece of Hyderabad ’s history that often goes unnoticed. Nestled in the heart of this busy city is the Nizam’s Rubath, a legacy that dates back centuries. Established with the purpose of providing free accommodation for pilgrims traveling from the Deccan region, the Rubath has long been a symbol of Hyderabadi hospitality and philanthropy. Its origins, deeply rooted in the vision of the Nizams, reflect their commitment to supporting their people on this holy journey. The Rubath Nizam Hyderabad in Makkah traces its origins to the mid-19th century during the reign of Afzal-ud-Daula, Asaf Jah V. Recognizing the challenges faced by pilgrims journeying from Hyderabad and surrounding regions to Makkah, the Nizam decided to create a sanctuary for them. While there is no historical evidence to support the number, legend has it that Afzal-ud-Daula established 42 Rubath buildings in 1860 to provide instant relief to those who faced long journeys. Notably, at that time Saudi Arabia was undergoing a financial crisis, as the country had yet to discover the oil reserves that would later transform its economy. The government was struggling to provide adequate facilities to the influx of pilgrims arriving for Hajj. The Nizam’s Rubath proved to be an invaluable resource, offering refuge and much-needed comfort to not only Hyderabadis but visitors from Marathwada and Karnataka. To ensure easy access to the Kaaba, the Rubath was strategically established near the haram. Over time, the Rubath only grew in importance and became a significant symbol of Hyderabad’s connection to Makkah. The Nizam’s Rubath in Makkah today is a blend of tradition and modernity. It continues to be a cornerstone for pilgrims during the Hajj pilgrimage. However, with the expansion of Makkah’s Grand Mosque and urban development, the number of Rubath buildings has significantly decreased and relocated further from the mosque. Today, only three buildings remain with a total capacity of about 1,200 people. Due to the shortage of accommodation, every year a limited number of Hajj pilgrims are selected through a draw. While the property provides modern-day amenities like air conditioning, free WiFi, free laundry, and much more, visitors remain unsatisfied. Speaking to Siasat.com , a doctor from Hyderabad said, “I stayed in the Nizam’s Rubath in Ramadan this year and the management was subpar with issues like maintenance. Though the facilities are decent, they do not reflect the kind of standard one might expect from such an iconic institution.” Another challenge facing Nizam’s Rubath is the expansion of the hospitality industry in Makkah. Despite offering free or subsidized accommodation, Hyderabadi visitors are opting for private hotels that provide better proximity to the Haram, shuttle services, and buffet options, which the Rubath struggles to match. Additionally, online booking platforms have made it easier for pilgrims to secure accommodations tailored to their needs, further reducing reliance on the Rubath. For a young Ruqia Fatima, comfort is the most important when choosing a hotel. “It is fascinating to learn about the Rubath’s history but the practicality of choosing a hotel closer to the Kaaba with better services makes it more appealing which is why I did not opt for the Rubath for my Umrah trip. The lack of information and reviews about the Rubath online also influenced my choice,” she says. It is to be noted that, despite these trends, the Rubath continues to serve as a symbol of Hyderabad’s enduring legacy in Makkah, reflecting a tradition of hospitality that has spanned over a century.Connor Clark & Lunn Investment Management Ltd. Raises Holdings in Casey’s General Stores, Inc. (NASDAQ:CASY)
Trump nominates Pam Bondi for new Attorney General after Matt Gaetz withdrawalNEW YORK , Dec. 13, 2024 /PRNewswire/ -- Agriculture & Natural Solutions Acquisition Corporation, a special purpose acquisition company ("ANSC"), announced today that the Treasurer of Australia (the "Treasurer") on December 12, 2024 (Australian Eastern Daylight Time) confirmed that the Commonwealth Government of Australia has no objection to ANSC's previously announced proposed business combination with Australian Food & Agriculture Company Limited ("AFA") and the other parties to the Business Combination Agreement dated August 28, 2024 (the "Business Combination") (known colloquially as "FIRB Approval" as the Treasurer is advised on such matters by the Foreign Investment Review Board). FIRB Approval is one of the conditions to closing of the Business Combination. ABOUT AFA AFA is a large-scale, diversified agricultural business established by the late Colin Bell in 1993 with the acquisition of the historic 'Burrabogie' station. AFA now operates one of the largest agricultural portfolios in New South Wales, Australia consisting of three major freehold title land aggregations within the Deniliquin, Hay and Coonamble districts, which total approximately 550,000 acres, and a water portfolio of approximately 45,000 acre-feet. AFA's portfolio includes some of Australia's most iconic properties, including 'Boonoke', 'Burrabogie', 'Wanganella' and 'Wingadee'. The company has total livestock carrying capacity of approximately 247,000 dry sheep equivalent across its sheep wool and meat and cattle operations (excluding the Conargo feedlot). AFA also operates the historic Wanganella and Poll Boonoke merino sheep studs, amongst the most highly regarded studs in Australia . AFA's cropping operations are characterized by flexibility amongst crop types, geographies and seasons. Key crops include irrigated cotton, irrigated rice, wheat, barley, canola, corn, chick peas and faba beans. More recently, the company has developed the state-of-the-art Conargo feedlot with a licensed capacity of 12,000 standard cattle units. ABOUT ANSC ANSC was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. ANSC represents a further expansion of its sponsors' 18-year franchise in low-carbon investments, having established industry leading, scaled companies with more than $6 billion of equity invested in renewables. FORWARD LOOKING STATEMENTS This document includes certain statements that may constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions, or results, and involve a number of known and unknown risks, uncertainties, assumptions, and other important factors, many of which are outside of ANSC, Agriculture & Natural Solutions Company Limited ACN 680 144 085 ("NewCo") or AFA's management's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements. Accordingly, forward-looking statements should not be relied upon as representing ANSC's, AFA's or NewCo's views as of any subsequent date, and none of ANSC, AFA or NewCo undertakes any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. None of NewCo, ANSC or AFA gives any assurance that any of NewCo, ANSC or AFA will achieve its expectations. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, NewCo's actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: (i) the ability of the parties to complete the Business Combination by ANSC's business combination deadline and the potential failure to obtain an extension of the business combination deadline if sought by ANSC; (ii) the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive agreements relating to the Business Combination; (iii) the outcome of any legal, regulatory or governmental proceedings that may be instituted against NewCo, ANSC or AFA or any investigation or inquiry following announcement of the Business Combination, including in connection with the Business Combination; (iv) the inability to complete the Business Combination due to the failure to obtain approval of ANSC's shareholders; (v) AFA's and NewCo's success in retaining or recruiting, or changes required in, their officers, key employees or directors following the Business Combination; (vi) the ability of the parties to obtain the listing of the ordinary shares in the capital of NewCo ("NewCo Ordinary Shares") and warrants to purchase NewCo Ordinary Shares on the New York Stock Exchange or another national securities exchange upon the closing of the Business Combination; (vii) the risk that the Business Combination disrupts current plans and operations of AFA as a result of the announcement and consummation of the transactions described herein; (viii) the ability to recognize the anticipated benefits of the Business Combination; (ix) unexpected costs related to the Business Combination, which may be affected by, among other things, competition and the ability of AFA to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its key employees; (x) the ability of the parties to consummate one or more private placements of securities of NewCo to be consummated in connection with the Business Combination (the "Private Placements") on the stated timeline; (xi) the use of proceeds from the Private Placements by the combined company; (xii) the risk that there will be insufficient cash raised through the Private Placements, or that the amount of redemptions by ANSC's public shareholders is greater than expected; (xiii) the management and board composition of NewCo following completion of the Business Combination; (xiv) limited liquidity and trading of NewCo's securities; (xv) geopolitical risk and changes in applicable laws or regulations, including legal or regulatory developments (including, without limitation, accounting considerations) which could result in the need for AFA to restate its historical financial statements and cause unforeseen delays in the timing of the Business Combination and negatively impact the trading price of NewCo's securities and the attractiveness of the Business Combination to investors; (xvi) the possibility that AFA may be adversely affected by other economic, business, and/or competitive factors; (xvii) operational risks; (xviii) the possibility that a pandemic or major disease disrupts AFA's business; (xix) litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on AFA's resources; (xx) the risks that the consummation of the Business Combination is substantially delayed or does not occur including the risk that the transaction may not be completed by ANSC's business combination deadline and the potential failure to obtain extensions of the business combination deadline if sought by ANSC; and (xxi) other risks and uncertainties indicated from time to time in the proxy statement/prospectus relating to the Business Combination, including those under "Risk Factors" therein, and in ANSC's, AFA's and NewCo's other filings with the SEC. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. No Offer or Solicitation This communication relates to a proposed business combination between AFA and ANSC. This document shall not constitute a "solicitation" of a proxy, consent, or authorization, as defined in Section 14 of the Exchange Act, with respect to any securities or in respect of the Business Combination. This document also does not constitute an offer, or a solicitation of an offer, to buy, sell, or exchange any securities, investment or other specific product, or a solicitation of any vote or approval, nor shall there be any offer, sale or exchange of securities, investment or other specific product in any jurisdiction in which such offer, solicitation or sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities will be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or an exemption therefrom. Additional Information About the Business Combination and Where To Find It In connection with the Business Combination, ANSC, NewCo and AFA intend to file a registration statement on Form F-4 relating to the Business Combination (the "Registration Statement") with the SEC, which will include a proxy statement of ANSC in connection with ANSC's extraordinary general meeting of its shareholders (the "ANSC Shareholders' Meeting") and certain other related matters described in the Registration Statement. The Registration Statement, including the proxy statement/prospectus contained therein, will contain important information about the Business Combination and the other matters to be voted upon at the ANSC Shareholders' Meeting. This communication does not contain all the information that should be considered concerning the Business Combination and other matters and is not intended to provide the basis for any investment decision or any other decision in respect of such matters. ANSC, AFA and NewCo may also file other documents with the SEC regarding the Business Combination. INVESTORS AND SECURITY HOLDERS OF ANSC AND OTHER INTERESTED PERSONS ARE URGED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, INCLUDING THE PROXY STATEMENT/PROSPECTUS INCLUDED THEREIN, ANY AMENDMENTS THERETO AND DOCUMENTS INCORPORATED BY REFERENCE, AND ANY OTHER RELEVANT DOCUMENTS THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH THE BUSINESS COMBINATION CAREFULLY AND IN THEIR ENTIRETY BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT ANSC, NEWCO, AFA, AND THE BUSINESS COMBINATION. After the Registration Statement is declared effective by the SEC, ANSC will mail the definitive proxy statement/prospectus relating to the Business Combination to its shareholders as of the record date established for voting on the Business Combination. Shareholders will also be able to obtain copies of the preliminary proxy statement/prospectus, the definitive proxy statement/prospectus and other relevant materials in connection with the Business Combination without charge, once available, at the SEC's website at www.sec.gov or by directing a request to: Agriculture & Natural Solutions Acquisition Corporation, 712 Fifth Avenue, 36 th Floor, New York, NY 10019. Participants in the Solicitation ANSC, NewCo, AFA and their respective directors and executive officers and related persons may be deemed participants in the solicitation of proxies from ANSC's shareholders in connection with the Business Combination. ANSC's shareholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of ANSC and their direct or indirect interests therein in ANSC's Form 10-K filed with the SEC on March 28, 2024 (File No. 001-41861), including, without limitation, "Item 10. Directors, Executive Officers and Corporate Governance", "Item 11. Executive Compensation", "Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters" and "Item 13. Certain Relationships and Related Transactions, and Director Independence". Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies to ANSC's shareholders in connection with the Business Combination and other matters to be voted upon at the ANSC Shareholders' Meeting will be set forth in the proxy statement/prospectus for the Business Combination when available. You may obtain free copies of these documents as described above. Media Contact Daniel Yunger / Emma Cloyd Kekst CNC daniel.yunger@kekstcnc.com / emma.cloyd@kekstcnc.com View original content: https://www.prnewswire.com/news-releases/agriculture--natural-solutions-acquisition-corporation-receives-firb-approval-in-connection-with-previously-announced-business-combination-302331743.html SOURCE Agriculture & Natural Solutions Acquisition Corporation
Nigeria, Saudi Arabia forge stronger ties on export credit, insurance, and market accessShares of Inari Medical, Inc. ( NASDAQ:NARI – Get Free Report ) have received a consensus rating of “Hold” from the eleven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $58.89. A number of equities research analysts have recently issued reports on NARI shares. Wells Fargo & Company cut their price objective on shares of Inari Medical from $84.00 to $65.00 and set an “overweight” rating for the company in a research report on Wednesday, July 31st. Needham & Company LLC restated a “hold” rating on shares of Inari Medical in a research report on Tuesday, October 29th. Stifel Nicolaus assumed coverage on Inari Medical in a research report on Tuesday, September 17th. They set a “hold” rating and a $50.00 price objective on the stock. Leerink Partnrs upgraded Inari Medical to a “hold” rating in a research note on Tuesday, September 3rd. Finally, Piper Sandler raised their target price on shares of Inari Medical from $50.00 to $52.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 29th. Read Our Latest Stock Analysis on Inari Medical Insider Buying and Selling at Inari Medical Institutional Investors Weigh In On Inari Medical A number of hedge funds have recently bought and sold shares of NARI. Bessemer Group Inc. increased its holdings in shares of Inari Medical by 16.4% in the 1st quarter. Bessemer Group Inc. now owns 2,439 shares of the company’s stock worth $117,000 after buying an additional 344 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Inari Medical by 7.7% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 4,852 shares of the company’s stock worth $234,000 after purchasing an additional 348 shares during the period. Arizona State Retirement System increased its position in shares of Inari Medical by 2.5% during the 2nd quarter. Arizona State Retirement System now owns 14,602 shares of the company’s stock valued at $703,000 after purchasing an additional 358 shares during the last quarter. Covestor Ltd raised its holdings in Inari Medical by 30.2% during the 1st quarter. Covestor Ltd now owns 1,619 shares of the company’s stock valued at $78,000 after buying an additional 376 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in Inari Medical by 83.5% in the second quarter. Nisa Investment Advisors LLC now owns 956 shares of the company’s stock worth $46,000 after buying an additional 435 shares during the last quarter. Hedge funds and other institutional investors own 90.98% of the company’s stock. Inari Medical Trading Down 0.2 % Shares of NASDAQ NARI opened at $49.66 on Monday. Inari Medical has a 12-month low of $36.73 and a 12-month high of $67.13. The firm has a market capitalization of $2.91 billion, a price-to-earnings ratio of -36.78 and a beta of 0.96. The firm has a 50 day moving average of $45.60 and a 200 day moving average of $47.21. Inari Medical Company Profile ( Get Free Report Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. Featured Stories Receive News & Ratings for Inari Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inari Medical and related companies with MarketBeat.com's FREE daily email newsletter .